The Company thanks Anne for her many contributions overseeing our branded business and for her ongoing support to transition the dermatology business to Bill Humphries. Rob Rosiello will also depart the Company on December 31, 2016. Rob previously served as the Valeant CFO from July 2015 through August 2016 and has successfully transitioned the role to our new CFO, Paul Herendeen. "Rob is a trusted colleague who led our team through a financial restatement, and spearheaded efforts to strengthen our finance team," said Mr. Papa. Dr. Ari Kellen, EVP & Company Group Chairman will also depart Valeant on December 31, 2016. The Company is grateful to Ari for his leadership across many of our businesses and his influence on our pipeline will undoubtedly continue to benefit the Company into the future. Dr. Kellen and Mr. Rosiello will continue to serve as consultants on an ongoing basis.